Sector
—
Target Customer
—
Core Technology
—
Tags (4)
regenerative-medicinedentalhealthcaremedical-technologies
Dentsply Sirona Financials
Dentsply Sirona Lifecycle
Dentsply Sirona News
5 articles
3 Low-Volatility Stocks in Dangerous Territory
The article discusses the investment risks associated with three low-volatility stocks: Zumiez, Dentsply Sirona, and Amdocs. Zumiez, a retailer of street and skate apparel, faces challenges due to lagging same-store sales and poor expense management, leading to a significant drop in earnings per share over the past six years. Dentsply Sirona, a manufacturer of dental equipment, struggles with weak growth and declining profitability. Amdocs, a provider of software and services for telecommunications companies, experiences slow backlog growth and a projected sales decline. The article advises caution with these stocks and suggests exploring better investment opportunities.
Dentsply Sirona Acquires Datum Dental
Dentsply Sirona has acquired Datum Dental and its OSSIX regenerative solutions portfolio. The acquisition will open up significant opportunities for Dentsply Sirona within its Implants segment. The transaction is expected to close in January 2021.
Acquisition
Datum Dental, Ltd. and Dentsply Sirona Implants Enter Distribution Agreement in the USA
Datum Dental, a leading provider of bone and tissue regeneration solutions for dentistry, has announced the expansion of its global distribution network. The companys OSSIX products, powered by its patented GLYMATRIX technology, are now being promoted by Dentsply Sirona Implants in the USA. The distribution collaboration was announced at the Academy of Osseointegration Annual Meeting. Datum Dental has also expanded its Sales & Marketing team to support the growth of the OSSIX brand. The companys partner network is also extending its reach to new territories. Datum Dental aims to enhance the future of implantology and oral care with its innovative dental regeneration products.
PartnersExpand
"Our triangular implant leaves more room for bone"
Dental implant company MIS Implants Technologies has been sold to Dentsply Sirona for $375 million. MIS had $80 million in revenue at the time of the acquisition. The company was founded by Doron Peretz and Eitan Peretz and had a large production facility in Israel. MIS specializes in dental implants and has a strong brand name in the market. The company will continue as a separate unit within Dentsply, maintaining its personnel and production capabilities.
InvestmentAcquisition
DENTSPLY Sirona Set to Acquire MIS Implants for $375M
Dentsply Sirona Team
No team members listed.
Employee Info
| Employees (range) | 11-50 |
| Exact count | 31 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).